文献速递介入腹部PETMRDSA

钇-90放射栓塞中可快速吸收明胶微球暂时性血流调节保护非肿瘤肝组织的初步临床试验

Transient flow modulation with rapid-resorbable gelatin microspheres during Yttrium-90 radioembolization for liver cancer: a preliminary clinical trial.
PubMed 文献 · Eur Radiol · 2026-10-08

这项II期试验纳入20例肝癌患者,在钇-90放射栓塞前用560-800 µm可快速吸收明胶微球暂时减少非肿瘤肝组织血流,主要终点为钇-90 PET/CT上非肿瘤肝组织的保护率。中位保护率为35.8%,7例(35%)肿瘤/非肿瘤肝组织摄取比相较治疗前SPECT/CT增加≥2倍,EOB-MRI肝胆期信号强度比从基线1.03显著升至6个月随访1.29(p<0.001)。

要点

  • 钇-90 PET/CT可定量评估明胶微球对非肿瘤肝组织的保护率,中位35.8%。
  • EOB-MRI肝胆期信号强度比可用于随访评估区域肝功能保护。
  • 非肿瘤肝组织钇-90微球负荷越低,保护率越高。

关键影像表现/征象

  • 中位保护率为35.8%(IQR 20.2-66.7)。
  • 7例(35%,7/20)患者钇-90 PET/CT上肿瘤/非肿瘤肝组织摄取比较治疗前SPECT/CT增加≥2倍。
  • EOB-MRI肝胆期保护区与非保护区非肿瘤肝组织信号强度比从基线中位1.03(IQR 0.97-1.05)显著升至6个月随访中位1.29(IQR 1.18-1.54;p<0.001)。

诊断标准与关键数值

  • 非肿瘤肝组织钇-90微球负荷与保护率呈负相关(ρ=-0.578,p=0.010)。
  • 保护率与6个月时信号强度比呈正相关(ρ=0.710,p=0.001)。
  • 保护率定义为钇-90 PET/CT上明胶微球栓塞区与非栓塞区非肿瘤肝组织的比较。

临床应用与阅片要点

  • 钇-90 PET/CT可用于评估血流调节后非肿瘤肝组织的微球沉积减少程度。
  • EOB-MRI肝胆期信号强度比可作为随访区域肝功能保护的影像指标。
  • 后续行肝动脉内治疗的患者均实现完全动脉再通,提示明胶微球暂时性栓塞不影响后续血管通路。

局限性

  • 初步临床试验,样本量20例,单中心设计。
  • 原文未报告随机对照或盲法设计。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To explore the effectiveness of rapid-resorbable gelatin microspheres (RGMs) for protecting non-tumorous liver (NTL) through flow modulation during yttrium-90 (Y-90) radioembolization for liver cancer.

MATERIALS AND METHODS: This phase II trial defined the primary outcome as the protection rate of RGM-embolized vs non-embolized NTL on Y-90 PET/CT. RGMs (560-800 µm) were used to transiently diminish blood flow to the NTL, followed by Y-90 microsphere administration. The effectiveness of flow modulation and radioembolization was assessed using Y-90 PET/CT and gadoxetic acid-enhanced MRI (EOB-MRI).

RESULTS: Twenty patients were enrolled between March 2023 and January 2025. The median protection rate was 35.8% (interquartile range [IQR], 20.2-66.7). Seven patients (35%, 7/20) demonstrated a ≥ 2-fold increase in the tumor-to-NTL uptake ratio on Y-90 PET/CT compared with pre-treatment SPECT/CT. The signal intensity (SI) ratio between protected and unprotected NTLs on the hepatobiliary phase of EOB-MRI increased significantly from baseline (median, 1.03; IQR, 0.97-1.05) to 6-month follow-up (median, 1.29; IQR, 1.18-1.54; p < 0.001). The Y-90 microsphere load to the NTL was negatively correlated with the protection rate (ρ = -0.578, p = 0.010), whereas the protection rate was positively correlated with the SI ratio at 6 months (ρ = 0.710, p = 0.001). All patients who underwent subsequent intra-arterial treatments achieved complete arterial recanalization.

CONCLUSION: RGM-mediated flow modulation was associated with reduced Y-90 microsphere deposition in the NTL, with imaging findings suggesting regional liver function preservation. This protective effect appeared greater with lower Y-90 microsphere load.

KEY POINTS: Question Can flow modulation using RGMS preserve regional liver function? Findings Prior embolization with rapidly resorbable gelatin microspheres reduced the absorbed dose to the NTL by 35.8% and preserved signal intensity on EOB-MRI after radioembolization. Clinical relevance RGMs can transiently divert arterial flow away from the NTL, reducing Yttrium-90 microsphere influx and helping preserve regional liver function during Yttrium-90 radioembolization for liver cancer.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Choi JW, Suh M, Kim JH, et al. Transient flow modulation with rapid-resorbable gelatin microspheres during Yttrium-90 radioembolization for liver cancer: a preliminary clinical trial. Eur Radiol. 2026. PMID: 42848039. doi:10.1007/s00330-026-12943-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。